Selected research
Industry Research
Toxicity Estimation Software Tool (TEST) Industry Research Report 2026
Market perspective
The global Toxicity Estimation Software Tool (TEST) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Toxicity Estimation Software Tool (TEST) market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Toxicity Estimation Software Tool (TEST) market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Toxicity Estimation Software Tool (TEST) market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Toxicity Estimation Software Tool (TEST) include Inotiv, Simulations Plus Inc, Schrodinger, Aclaris, Evogene, Deciphex (Patholytix), Exscientia, Instem (Leadscope) and Lhasa Limited and among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Toxicity Estimation Software Tool (TEST) market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Toxicity Estimation Software Tool (TEST).
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Toxicity Estimation Software Tool (TEST) Market by Company
Inotiv
Simulations Plus Inc
Schrodinger
Aclaris
Evogene
Deciphex (Patholytix)
Exscientia
Instem (Leadscope)
Lhasa Limited
MultiCASE
Toxicity Estimation Software Tool (TEST) Segment by Type
On-Premise
Cloud-Based
Toxicity Estimation Software Tool (TEST) Segment by Application
Academia
Enterprise
Toxicity Estimation Software Tool (TEST) Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Toxicity Estimation Software Tool (TEST) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Toxicity Estimation Software Tool (TEST) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Toxicity Estimation Software Tool (TEST).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Toxicity Estimation Software Tool (TEST) companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- On-Premise
- Cloud-Based
Applications
- Academia
- Enterprise
Companies covered
- Inotiv
- Simulations Plus Inc
- Schrodinger
- Aclaris
- Evogene
- Deciphex (Patholytix)
- Exscientia
- Instem (Leadscope)
- Lhasa Limited
- MultiCASE
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Toxicity Estimation Software Tool (TEST) by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 On-Premise
- 2.2.3 Cloud-Based
- 2.3 Toxicity Estimation Software Tool (TEST) by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Academia
- 2.3.3 Enterprise
- 2.4 Assumptions and Limitations
3 Toxicity Estimation Software Tool (TEST) Breakdown Data by Type
- 3.1 Global Toxicity Estimation Software Tool (TEST) Historic Market Size by Type (2021-2026)
- 3.2 Global Toxicity Estimation Software Tool (TEST) Forecasted Market Size by Type (2027-2032)
4 Toxicity Estimation Software Tool (TEST) Breakdown Data by Application
- 4.1 Global Toxicity Estimation Software Tool (TEST) Historic Market Size by Application (2021-2026)
- 4.2 Global Toxicity Estimation Software Tool (TEST) Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Toxicity Estimation Software Tool (TEST) Market Perspective (2021-2032)
- 5.2 Global Toxicity Estimation Software Tool (TEST) Growth Trends by Region
- 5.2.1 Global Toxicity Estimation Software Tool (TEST) Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Toxicity Estimation Software Tool (TEST) Historic Market Size by Region (2021-2026)
- 5.2.3 Toxicity Estimation Software Tool (TEST) Forecasted Market Size by Region (2027-2032)
- 5.3 Toxicity Estimation Software Tool (TEST) Market Dynamics
- 5.3.1 Toxicity Estimation Software Tool (TEST) Industry Trends
- 5.3.2 Toxicity Estimation Software Tool (TEST) Market Drivers
- 5.3.3 Toxicity Estimation Software Tool (TEST) Market Challenges
- 5.3.4 Toxicity Estimation Software Tool (TEST) Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Toxicity Estimation Software Tool (TEST) Players by Revenue
- 6.1.1 Global Top Toxicity Estimation Software Tool (TEST) Players by Revenue (2021-2026)
- 6.1.2 Global Toxicity Estimation Software Tool (TEST) Revenue Market Share by Players (2021-2026)
- 6.2 Global Toxicity Estimation Software Tool (TEST) Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Toxicity Estimation Software Tool (TEST) Head Office and Area Served
- 6.4 Global Toxicity Estimation Software Tool (TEST) Players, Product Type & Application
- 6.5 Global Toxicity Estimation Software Tool (TEST) Manufacturers Established Date
- 6.6 Global Toxicity Estimation Software Tool (TEST) Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Toxicity Estimation Software Tool (TEST) Market Size (2021-2032)
- 7.2 North America Toxicity Estimation Software Tool (TEST) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Toxicity Estimation Software Tool (TEST) Market Size by Country (2021-2026)
- 7.4 North America Toxicity Estimation Software Tool (TEST) Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Toxicity Estimation Software Tool (TEST) Market Size (2021-2032)
- 8.2 Europe Toxicity Estimation Software Tool (TEST) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Toxicity Estimation Software Tool (TEST) Market Size by Country (2021-2026)
- 8.4 Europe Toxicity Estimation Software Tool (TEST) Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Toxicity Estimation Software Tool (TEST) Market Size (2021-2032)
- 9.2 Asia-Pacific Toxicity Estimation Software Tool (TEST) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Toxicity Estimation Software Tool (TEST) Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Toxicity Estimation Software Tool (TEST) Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Toxicity Estimation Software Tool (TEST) Market Size (2021-2032)
- 10.2 South America Toxicity Estimation Software Tool (TEST) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Toxicity Estimation Software Tool (TEST) Market Size by Country (2021-2026)
- 10.4 South America Toxicity Estimation Software Tool (TEST) Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Toxicity Estimation Software Tool (TEST) Market Size (2021-2032)
- 11.2 Middle East & Africa Toxicity Estimation Software Tool (TEST) Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Toxicity Estimation Software Tool (TEST) Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Toxicity Estimation Software Tool (TEST) Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Inotiv
- 12.1.1 Inotiv Company Information
- 12.1.2 Inotiv Business Overview
- 12.1.3 Inotiv Revenue in Toxicity Estimation Software Tool (TEST) Business (2021-2026)
- 12.1.4 Inotiv Toxicity Estimation Software Tool (TEST) Product Portfolio
- 12.1.5 Inotiv Recent Developments
- 12.2 Simulations Plus Inc
- 12.2.1 Simulations Plus Inc Company Information
- 12.2.2 Simulations Plus Inc Business Overview
- 12.2.3 Simulations Plus Inc Revenue in Toxicity Estimation Software Tool (TEST) Business (2021-2026)
- 12.2.4 Simulations Plus Inc Toxicity Estimation Software Tool (TEST) Product Portfolio
- 12.2.5 Simulations Plus Inc Recent Developments
- 12.3 Schrodinger
- 12.3.1 Schrodinger Company Information
- 12.3.2 Schrodinger Business Overview
- 12.3.3 Schrodinger Revenue in Toxicity Estimation Software Tool (TEST) Business (2021-2026)
- 12.3.4 Schrodinger Toxicity Estimation Software Tool (TEST) Product Portfolio
- 12.3.5 Schrodinger Recent Developments
- 12.4 Aclaris
- 12.4.1 Aclaris Company Information
- 12.4.2 Aclaris Business Overview
- 12.4.3 Aclaris Revenue in Toxicity Estimation Software Tool (TEST) Business (2021-2026)
- 12.4.4 Aclaris Toxicity Estimation Software Tool (TEST) Product Portfolio
- 12.4.5 Aclaris Recent Developments
- 12.5 Evogene
- 12.5.1 Evogene Company Information
- 12.5.2 Evogene Business Overview
- 12.5.3 Evogene Revenue in Toxicity Estimation Software Tool (TEST) Business (2021-2026)
- 12.5.4 Evogene Toxicity Estimation Software Tool (TEST) Product Portfolio
- 12.5.5 Evogene Recent Developments
- 12.6 Deciphex (Patholytix)
- 12.6.1 Deciphex (Patholytix) Company Information
- 12.6.2 Deciphex (Patholytix) Business Overview
- 12.6.3 Deciphex (Patholytix) Revenue in Toxicity Estimation Software Tool (TEST) Business (2021-2026)
- 12.6.4 Deciphex (Patholytix) Toxicity Estimation Software Tool (TEST) Product Portfolio
- 12.6.5 Deciphex (Patholytix) Recent Developments
- 12.7 Exscientia
- 12.7.1 Exscientia Company Information
- 12.7.2 Exscientia Business Overview
- 12.7.3 Exscientia Revenue in Toxicity Estimation Software Tool (TEST) Business (2021-2026)
- 12.7.4 Exscientia Toxicity Estimation Software Tool (TEST) Product Portfolio
- 12.7.5 Exscientia Recent Developments
- 12.8 Instem (Leadscope)
- 12.8.1 Instem (Leadscope) Company Information
- 12.8.2 Instem (Leadscope) Business Overview
- 12.8.3 Instem (Leadscope) Revenue in Toxicity Estimation Software Tool (TEST) Business (2021-2026)
- 12.8.4 Instem (Leadscope) Toxicity Estimation Software Tool (TEST) Product Portfolio
- 12.8.5 Instem (Leadscope) Recent Developments
- 12.9 Lhasa Limited
- 12.9.1 Lhasa Limited Company Information
- 12.9.2 Lhasa Limited Business Overview
- 12.9.3 Lhasa Limited Revenue in Toxicity Estimation Software Tool (TEST) Business (2021-2026)
- 12.9.4 Lhasa Limited Toxicity Estimation Software Tool (TEST) Product Portfolio
- 12.9.5 Lhasa Limited Recent Developments
- 12.10 MultiCASE
- 12.10.1 MultiCASE Company Information
- 12.10.2 MultiCASE Business Overview
- 12.10.3 MultiCASE Revenue in Toxicity Estimation Software Tool (TEST) Business (2021-2026)
- 12.10.4 MultiCASE Toxicity Estimation Software Tool (TEST) Product Portfolio
- 12.10.5 MultiCASE Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst